Olanzapine-associated Hair Loss in an Adolescent: A Case Report
Journal of Indian Association for Child and Adolescent Mental Health · 04.08.2026
DOI: 10.1177/09731342261472573 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Indian Association for Child and Adolescent Mental Health, online erschienen am 04.08.2026. Verfasst von Aashmeen Kaur und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Drug-induced alopecia is a reversible but distressing adverse effect of psychotropic medications. Although most commonly associated with mood stabilizers, hair loss has also been reported, albeit infrequently, with antipsychotics. Olanzapine is widely used in adolescent psychiatry and is generally considered safe and effective. However, alopecia related to its use is rarely described, particularly in adolescents. We report a case of a 16-year-old female with schizophrenia who developed diffuse hair loss following treatment with olanzapine, with complete resolution after discontinuation.
Zitieren
APA
Kaur, A., Kudrat, J., & Khakha, R. (2026). Olanzapine-associated Hair Loss in an Adolescent: A Case Report. Journal of Indian Association for Child and Adolescent Mental Health. https://doi.org/10.1177/09731342261472573
Vancouver
Kaur A, Kudrat J, Khakha R. Olanzapine-associated Hair Loss in an Adolescent: A Case Report. Journal of Indian Association for Child and Adolescent Mental Health. 2026. doi:10.1177/09731342261472573
BibTeX
@article{Kaur2026,
author = {Kaur, Aashmeen and Kudrat, Jain and Khakha, Regina},
title = {Olanzapine-associated Hair Loss in an Adolescent: A Case Report},
journal = {Journal of Indian Association for Child and Adolescent Mental Health},
year = {2026},
doi = {10.1177/09731342261472573}
}
EUVIMED